Overcoming Barriers to Biosimilar Adoption: Commentary on "Cost to Medicare of Delayed Adalimumab Biosimilar Availability". Issue 1 (6th September 2021)

Record Type:: Journal Article
Title:: Overcoming Barriers to Biosimilar Adoption: Commentary on "Cost to Medicare of Delayed Adalimumab Biosimilar Availability". Issue 1 (6th September 2021)
Main Title:: Overcoming Barriers to Biosimilar Adoption: Commentary on "Cost to Medicare of Delayed Adalimumab Biosimilar Availability"
Authors:: Arad, Nitzan
Kroetsch, Adam
McClellan, Mark
Abstract:
Is Part Of:: Clinical pharmacology & therapeutics. Volume 112:Issue 1(2022)
Journal:: Clinical pharmacology & therapeutics
Issue:: Volume 112:Issue 1(2022)
Issue Display:: Volume 112, Issue 1 (2022)
Year:: 2022
Volume:: 112
Issue:: 1
Issue Sort Value:: 2022-0112-0001-0000
Page Start:: 25
Page End:: 27
Publication Date:: 2021-09-06
Subjects:: Pharmacology -- Periodicals
Therapeutics -- Periodicals
615.5
Journal URLs:: http://www.nature.com/clpt/index.html ↗
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1532-6535 ↗
http://www.nature.com/ ↗
http://firstsearch.oclc.org ↗
http://www.mosby.com/cpt ↗
http://www.sciencedirect.com/science/journal/00099236 ↗
http://www2.us.elsevierhealth.com/scripts/om.dll/serve?action=searchDB&searchdbfor=home&id=cp ↗
DOI:: 10.1002/cpt.2403 ↗
Languages:: English
ISSNs:: 0009-9236
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3286.330000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 22092.xml